Multiple bone lesions after allogeneic bone marrow transplantation in a patient with relapsed adult acute lymphoblastic leukemia: minimal residual disease analysis may predict extramedullary relapse.
We describe a patient with acute lymphoblastic leukemia (ALL, L2) who relapsed with multiple bone lesions after allogeneic bone marrow transplantation (allo-BMT). Allo-BMT was performed from an HLA-identical sibling during the first hematological complete remission (CR). Minimal residual disease (MRD) assessed by polymerase chain reaction (PCR) with primers for T cell receptor delta (TCRdelta) gene became positive in the bone marrow sample on day 46 after allo-BMT. On day 113, the patient complained of a painful tumor at the right clavicle. The examination of biopsy specimen revealed infiltration of leukemic cells. After partial response was achieved by local radiotherapy, disseminated bone lesions were demonstrated by 99mTC scintigraphy scan, followed by bone marrow relapse on day 137. The patient died of cardiac tamponade on day 236 after Allo-BMT. MRD assessed by PCR assay for TCRdelta gene in the bone marrow is useful for the prediction of extramedullary as well as medullary relapse after BMT.
Nomura
K
K
Third Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan. nomuken@sun.kpu-m.ac.jp
Okamoto
T
T
Nakao
M
M
Ueda
K
K
Akano
Y
Y
Fujita
Y
Y
Kobayashi
M
M
Yokota
S
S
Horiike
S
S
Nishida
K
K
Kusuzaki
K
K
Taniwaki
M
M
D000328:Adult; D001847:Bone Diseases / Q000000981:diagnostic imaging / Q000209:etiology*; D016026:Bone Marrow Transplantation; D015329:Gene Rearrangement, T-Lymphocyte; D019675:Genes, T-Cell Receptor gamma; D006801:Humans; D008297:Male; D018365:Neoplasm, Residual; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000628:therapy*; D011877:Radionuclide Imaging; D012008:Recurrence; D014184:Transplantation, Homologous